Recent studies suggested that the aberrant regulation of signaling pathways such as ROS, NF-κB, Wnt/β-catenin, or Hedgehog pathway is critical to the pathogenesis of CD34+ AML cells [[11], [12], [13], [14], [15], [16], [17]]. This evidence concerns the gene CD34 and acute myeloid leukemia.